Use of 68Ga-DOTATOC PET/CT-enterography for Detection of the Primary Lesion in Neuroendocrine Tumors of the Small Bowel
Recruiting
N/A
Interventional Study
Small Bowel Neoplasia
Neuroendocrine (NE) Tumors
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 18 (estimated)
- Sponsor
- European Institute of Oncology · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The neuroendocrine neoplasms of the small intestine (Si-NENs) is a relatively rare malignancy. Surgical resection is the only curative treatment for the early-stage. It remains controversial its application for advanced metastatic gastroenteropancreatic neuroendocrine tumours (GEP-NETs).
The identification of metastatic disease and tumor grade are the most important prognostic factors in advanced…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* patients with small bowel neuroendocrine tumours
* tumors with any grade (from 1 to 3) and any Ki 67 percentage
* patients eligible for surgical resection
Exclusion Criteria:
* patients with synchronous other oncological disease
* patients with Inflammatory bowel disease
* p…
Contacts